This survey aims to look at individual practice and can be completed by any healthcare professional.

Size: px
Start display at page:

Download "This survey aims to look at individual practice and can be completed by any healthcare professional."

Transcription

1 This survey aims to look at individual practice and can be completed by any healthcare professional. If you have any questions about how this form should be completed please contact Dr Grace Ting or Dr Andrew Khodabukus Thank you. 1

2 * 1. Your Profession * 2. Your Location & Service * 3. In which healthcare setting do you MAINLY work in? (Please select only 1 option) Specialist Palliative Care - Community Specialist Palliative Care - Hospice Specialist Palliative Care - Hospital Primary Care Hepatology and Gastroenterology Critical Care Acute Medicine (Emergency Department / Accidents and Emergencies Department / Medical Assessment Unit / Urgent Care) 2

3 * 4. Select the top 3 common reasons which would prompt your referral of a patient with end stage liver disease to specialist palliative care (Please select only 3) Complex symptom control End of life care Hospice admission required Advance care planning Family support Advice on ongoing management of recurrent ascites * 5. Which prognostic indicator for assessing liver disease do you ROUTINELY use Child-Pugh MELD UKELD I do not routinely use a liver prognostic score Other /Comments (please specify) * 6. For the following scenarios, please select case(s) you consider specialist palliative care input would be appropriate. (Please tick all that apply) 56 year old male. Compensated Childs A Non-Alcoholic Steatohepatitis (NASH) cirrhosis. Seen 6 monthly in stable cirrhosis clinic. 47 year old woman. Primary biliary cirrhosis - UK End-stage Liver Disease (UKELD) score of 52. Listed for transplantation. 78 year old man. NASH cirrhosis with diuretic resistant ascites and renal impairment. 2 weekly outpatient paracentesis. 67 year old man with decompensated Childs B cirrhosis starting direct acting antiviral therapy for chronic hepatitis C virus infection. 37 year old woman. Alcohol dependency. Being discharged following 3 week admission for severe alcoholic hepatitis (first presentation) 52 year old man of no fixed abode. Ongoing addiction issues with alcohol and drug use. Recurrent A&E attendances. Child C cirrhosis with jaundice, ascites and grade 1 encephalopathy. 64 year old man. Hepatocellular carcinoma. Childs A cirrhosis. Delisted for transplantation as tumour now outside criteria for transplant list. Involvement of specialist palliative care is not appropriate in any of the above cases. * 7. What role do you think specialist palliative care has in the management of patients with end stage liver disease? 3

4 * 8. How confident are you in your knowledge and skills in looking after patients with end stage liver disease? (Please rate on a scale of 0 to 10; 0 = Not confident at all, 10 = Very confident) 0 = Not confident at all 5 = Neutral 10 = Very confident * 9. What training (if any) do you feel would improve your skills and knowledge in caring for patients with end stage liver disease? (Please rank in order of priority; 1 = most important, 7 = least important) Pharmacology of drugs used in end stage liver disease. Management of recurrent ascites. Management of hepatic encepalopathy Management of hepatorenal syndrome. Prevention and management of life-threatening haemorrhage. Social care and family support mechanisms. Advance care planning guidance * 10. Which strong opioid would be your first choice for managing pain in patients with end stage liver disease at the end of life with a preserved renal function? Morphine Oxycodone Hydromorphone Fentanyl Alfentanil * 11. Which strong opioid would be your first choice for managing pain in patients with end stage liver disease at the end of life with an impaired renal function? Morphine Oxycodone Hydromorphone Fentanyl Alfentanil 4

5 * 12. Which antiemetic would be your first choice for managing nausea and vomiting in patients with end stage liver disease at the end of life? Cyclizine Metoclopramide Levomepromazine Ondansetron Haloperidol * 13. Which medication would be your first choice for agitation in patients with end stage liver disease at the end of life? Midazolam Lorazepam Haloperidol Levomepromazine Phenobarbital * 14. Which medication would be your first choice for managing respiratory tract secretions in patients with end stage liver disease at the end of life? Hyoscine hydrobromide Hyoscine butylbromide Glycopyrronium * 15. What is your laxative of choice when managing hepatic encephalopathy? Laxido Senna Lactulose Docusate sodium Picolax Bisacodyl Enemas 5

6 * 16. How confident are you in managing life-threatening haemorrhage in end stage liver disease? (Please rate on a scale of 0 to 10; 0 = Not confident at all, 10 = Very confident) 0 = Not confident at all 5 = Neutral 10 = Very confident * 17. What do you find most challenging when managing patients with end stage liver disease in their last hours to days of life? (Please rank in order of 1 = most challenging, 10 = least challenging) Pain Agitation Delirium Recurrent ascites Pruritus Hepatic encephalopathy Haemorrhage Breathlessness Nausea / vomiting Respiratory tract secretions 6

7 This survey is now complete. Thank you for completing the survey. The results of this survey will be presented at the Regional Audit Meeting on 18th January 2018 at Marie Curie Hospice Liverpool. Click DONE to submit. 7

End Stage Liver Disease Regional Audit Casenote Survey

End Stage Liver Disease Regional Audit Casenote Survey 1. This questionnaire is an audit of clinical documentation of patients who have died of end stage liver disease. If you have any questions about how this form should be completed please contact Dr Grace

More information

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety Agitation & Anxiety (Exclude or treat REVERSIBLE causes*) Patient is anxious / frightened, but lucid Patient is confused, agitated and / or hallucinating MIDAZOLAM 2.5-5mg s/c (Max total 24 hour dose of

More information

PAIN MANAGEMENT Patient established on oral morphine or opioid naive.

PAIN MANAGEMENT Patient established on oral morphine or opioid naive. PAIN MANAGEMENT Patient established on oral morphine or opioid naive. Important; It is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member

More information

PAIN MANAGEMENT Person established taking oral morphine or opioid naive.

PAIN MANAGEMENT Person established taking oral morphine or opioid naive. PAIN MANAGEMENT Person established taking oral morphine or opioid naive. Important; it is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member

More information

Syringe driver in Palliative Care

Syringe driver in Palliative Care Syringe driver in Palliative Care Introduction: Syringe drivers are portable, battery operated devices widely used in palliative care to deliver medication as a continuous subcutaneous infusion over 24

More information

Algorithms for Symptom Management. In End of Life Care

Algorithms for Symptom Management. In End of Life Care Algorithms for Symptom Management In End of Life Care The Use of Drugs Beyond Licence (off label) -The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK regulates the activity of the

More information

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients.

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients. We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients. The closing date for responses is 19th December The results

More information

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT A collaboration between: St. Rocco s Hospice, Bridgewater Community Healthcare NHS Trust, NHS Warrington Clinical Commissioning Group,

More information

SYRINGE DRIVER MEDICATIONS

SYRINGE DRIVER MEDICATIONS SYRINGE DRIVER MEDICATIONS Christine Hull & Anita Webb Staff Nurses, Hospice in the Home 2015 Analgesics:- Groups of Medication used in Syringe Drivers Morphine sulphate Diamorphine Oxycodone Alfentanil

More information

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL If a patient is believed to be approaching the end of their life, medication should be prescribed in anticipation

More information

Renal Palliative Care Last Days of Life

Renal Palliative Care Last Days of Life Renal Palliative Care Last Days of Life Introduction This guideline is an aid to clinical decision-making and good practice for patients with stage 4-5 chronic kidney disease (egfr

More information

Care in the Last Days of Life

Care in the Last Days of Life Care in the Last Days of Life Introduction This guideline is an aid to clinical decision making and good practice in person-centred care for patients who are deteriorating and at risk of dying. The patient

More information

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE Reference: DCM029 Version: 1.1 This version issued: 07/06/18 Result of last review: Minor changes Date approved by owner (if applicable): N/A

More information

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL Doses of opiates must be proptional to current analgesic medication Please refer ALL patients on Methadone Ketamine to SPCT f advice. Patients

More information

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30) GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT These guidelines have been produced in collaboration with Dr Lucy Smyth, Consultant in Renal Medicine, Royal Devon and Exeter

More information

Treating patients with end-stage liver disease: Are we ready? Dr. Mino R. Mitri, M.D., C.M., M.Ed., FRCPC

Treating patients with end-stage liver disease: Are we ready? Dr. Mino R. Mitri, M.D., C.M., M.Ed., FRCPC Treating patients with end-stage liver disease: Are we ready? Dr. Mino R. Mitri, M.D., C.M., M.Ed., FRCPC mino.mitri@ubc.ca No Conflict of Interest 157 patients 157 patients 6 transplanted Criteria Liver

More information

Care of the Dying Management in Severe Renal Failure

Care of the Dying Management in Severe Renal Failure Care of the Dying Management in Severe Renal Failure Clinical Guideline Early recognition of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance

More information

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE EAST LANCASHIRE SPECIALIST PALLIATIVE CARE TEAM EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE Reviewed and updated August 2009 Next review date August 2011 Approved

More information

Symptom Management Guidelines for End of Life Care

Symptom Management Guidelines for End of Life Care Symptom Management Guidelines for End of Life Care The following pages are guidelines for the management of common symptoms in the last few days of life. General principles: 1. Consider how symptoms can

More information

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure. Care of the Dying Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance covers the prescribing and management of patients

More information

Care of the Dying Management in Severe Renal Failure

Care of the Dying Management in Severe Renal Failure Care of the Dying Management in Severe Renal Failure Clinical Guideline Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance

More information

Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO

Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO Anticipatory Medications for End of Life Patients oses must be proportional to the current analgesic medication Please refer ALL patients on Methadone or Ketamine to palliative care team for advice. Patients

More information

Palliative Care Impact Survey

Palliative Care Impact Survey September 2018 Contents Introduction...3 Headlines...3 Approach...4 Findings...4 Which guideline are used...4 How and where the guidelines are used...6 Alternative sources of information...7 Use of the

More information

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice. Bedfordshire Palliative Care Palliative Care Medicines Guidance This folder has been produced to support professionals providing palliative care in any setting. Its aim is to make best practice in palliative

More information

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text] [Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text] Patients with egfr greater than 30mL/min Patients with egfr less than 30mL/min Symptom Drug Dose Symptom Drug Dose

More information

SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number:

SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number: FILE IN PATIENT S COMMUNITY HEALTH RECORD FOLDER : SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRERIPTION & ADMINISTRATION RECORD (SPAR) Abbreviations used in this document to be listed here with the full

More information

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug COMMUNITY PRESCRIPTION CHART All entries should be in CAPITAL letters and in indelible black ink. If medications/ doses are stopped, cross through the relevant line clearly to avoid error. GP: PRESCRIBER

More information

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE Originally produced: July 2006 First Review: August 2009 Second Review: November 2011 For review November 2013 Approved

More information

End of life prescribing guidance

End of life prescribing guidance End of life prescribing guidance Introduction This guidance has been prepared to ASSIST IN DECISION MAKING for the prescribing and monitoring of medicines useful in the management of symptoms commonly

More information

Palliative care for heart failure patients. Susan Addie

Palliative care for heart failure patients. Susan Addie Palliative care for heart failure patients Susan Addie Treatments The most common limiting and distressing complaint is of fatigue and breathlessness. Optimal treatment strategies relieve symptoms, improves

More information

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life The following pages are guidelines for the management of common symptoms for a person thought to be

More information

Regional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2.

Regional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2. Regional Breathlessness Audit - Case te Survey 1. Introduction Please complete this form for your case note review. Cases used may be PROSPECTIVE AND/OR RETROSPECTIVE. Please log as many cases as you can.

More information

Opioids in the Community: Chronic pain, Palliative Care, and Addiction. Dr Ahmed Jakda September 2017

Opioids in the Community: Chronic pain, Palliative Care, and Addiction. Dr Ahmed Jakda September 2017 Opioids in the Community: Chronic pain, Palliative Care, and Addiction Dr Ahmed Jakda September 2017 Outline Context Background Action Delisting Highstrength Long- Acting Opioids Opioid use and prescribing

More information

Supportive Care. End of Life Phase

Supportive Care. End of Life Phase Supportive Care End of Life Phase Guidelines for Health Care Professionals In the care of patients with established renal failure who are in the last days of life References: Chambers E J (2004) End of

More information

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary Doncaster & Bassetlaw Cancer Locality Palliative Core Formulary Approved by Doncaster & Bassetlaw Hospitals NHS Foundation Trust Drugs and Therapeutics Committee. DJ14/2155 Oct 2014 Review date: Oct 2017

More information

Chronic Hepatic Disease

Chronic Hepatic Disease Chronic Hepatic Disease 10 th Leading Cause of Death Liver Functions Energy Metabolism Protein Synthesis Solubilization, Transport, and Storage Protects and Clears drugs, damaged cells Causes of Liver

More information

Isle of Wight Syringe Driver Compatibility Guidelines

Isle of Wight Syringe Driver Compatibility Guidelines Isle of Wight Syringe Driver Compatibility Guidelines Produced by The Earl Mountbatten Hospice, Isle of Wight Written January 2015, revision due January 2018 This guideline is available as a paper pocketbook

More information

Conservative Management of Uraemia

Conservative Management of Uraemia Conservative Management of Uraemia Information for Health Professionals Renal Department The York Hospital and Scarborough Hospital Tel: 01904 725370 For more information, please contact: The Renal Specialist

More information

Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30

Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30 If more information is required please seek help from specialist palliative care pioid dose conversion chart, syringe driver doses, rescue/prn doses and opioid patches Use the conversion chart to work

More information

Palliative Care Formulary

Palliative Care Formulary Palliative Care Formulary 2016-2019 This formulary for pain and symptom management in adults is intended as a guide for prescribers in hospital and community. Special care should be taken when prescribing

More information

Implementing the recommendation on medication management and symptom control

Implementing the recommendation on medication management and symptom control Implementing the recommendation on medication management and symptom control Mike Grocott Professor of Anaesthesia and Critical Care Medicine University of Southampton Consultant in Critical Care Medicine

More information

BACKGROUND Measuring renal function :

BACKGROUND Measuring renal function : A GUIDE TO USE OF COMMON PALLIATIVE CARE DRUGS IN RENAL IMPAIRMENT These guidelines bring together information and recommendations from the Palliative Care formulary (PCF5 ) BACKGROUND Measuring renal

More information

SCHEDULE 2 THE SERVICES

SCHEDULE 2 THE SERVICES SCHEDULE 2 THE SERVICES A. Service Specifications Mandatory headings 1 4: mandatory but detail for local determination and agreement Optional headings 5-7: optional to use, detail for local determination

More information

End of Life Care. Dr Anne Garry Consultant in Palliative Medicine

End of Life Care. Dr Anne Garry Consultant in Palliative Medicine End of Life Care Dr Anne Garry Consultant in Palliative Medicine Concerns voiced both by public and professionals.. Implementation and on-going training highly variable across country Decisions made by

More information

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: North Bristol 0117 4146392 UH Bristol 0117

More information

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth)

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth) Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth) Policy Number : DC020 Issue Date: October 2014 Review date: October 2016 Policy Owner: Head Community Services Monitor:

More information

Community and Mental Health Services. Palliative Care. Criteria and

Community and Mental Health Services. Palliative Care. Criteria and Community and Mental Health Services Specialist Palliative Care Service Referral Criteria and Guidance November 2018 Specialist Palliative Care Service Referrals These guidelines cover referrals for patients

More information

Anticipatory prescribing and end of life considerations. Dr Stephanie Lippett

Anticipatory prescribing and end of life considerations. Dr Stephanie Lippett Anticipatory prescribing and end of life considerations Dr Stephanie Lippett contents Pain Restlessness/agitation Nausea/vomiting Secretions Syringe driver Anticipatory prescribing Important things to

More information

Road Blocks in Non-Cancer Palliative Care Obstacles observed from outpatient non-cancer palliative practice.

Road Blocks in Non-Cancer Palliative Care Obstacles observed from outpatient non-cancer palliative practice. Road Blocks in Non-Cancer Palliative Care Obstacles observed from outpatient non-cancer palliative practice. 25th Annual Palliative Education and Research Days, West Edmonton Mall. Edmonton. 2014 Amanda

More information

NCEPOD - Measuring the Units; A review of patients who died with alcohol-related liver disease

NCEPOD - Measuring the Units; A review of patients who died with alcohol-related liver disease NCEPOD - Measuring the Units; A review of patients who died with alcohol-related liver disease Hospital Number Admission to hospital 5. Trusts should ensure that medical patients are reviewed by a consultant

More information

Palliative Care. Pocketbook 4

Palliative Care. Pocketbook 4 Nottinghamshire STP EOL Programme Board 2019 Review 2022 Palliative Care Pocketbook 4 Contents Pain Guidelines page 2 Nausea and Vomiting page 9 Inoperable Bowel Obstruction page 10 Constipation page 11

More information

Specialist Palliative Care Service Referral Criteria and Guidance

Specialist Palliative Care Service Referral Criteria and Guidance Specialist Palliative Care Service Referral Criteria and Guidance Specialist Palliative Care Service Referrals These guidelines cover referrals for patients with progressive terminal illness, whether

More information

Palliative Care for Primary Care Providers QUYNH BUI, MD MPH DECEMBER 2015

Palliative Care for Primary Care Providers QUYNH BUI, MD MPH DECEMBER 2015 Palliative Care for Primary Care Providers QUYNH BUI, MD MPH DECEMBER 2015 Objectives Define palliative care and primary palliative care Describe the rationale for providing primary palliative care in

More information

PALLIATIVE CARE IN END-STAGE LIVER DISEASE

PALLIATIVE CARE IN END-STAGE LIVER DISEASE PALLIATIVE CARE IN END-STAGE LIVER DISEASE Ken S. Ota, DO Family Medicine Banner Good Samaritan Medical Center Learning Objectives: Describe the common bio-psycho-social issues in end-stage liver disease

More information

The last days of life in hospital and at home

The last days of life in hospital and at home The last days of life in hospital and at home Beaumont Multi-disciplinary Palliative Care Study Day 28/9/2017 Dr Sarah McLean Consultant in Palliative Medicine St Francis Hospice Beaumont Hospital Overview

More information

SYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven

SYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven Bradford, Airedale, Wharfedale & Craven Managed Clinical Network SYMPTOM CONTROL IN THE LAST DAYS OF LIFE Guidelines for Healthcare Professionals Bradford, Airedale, Wharfedale & Craven Signs and symptoms

More information

Using syringe pumps in palliative care

Using syringe pumps in palliative care Using syringe pumps in palliative care Facilitator: Barbara Stone RN Ground rules Medication matching game Learning outcomes To identify the indications for using a syringe pump To discuss the general

More information

Respiratory Secretions. Care in the last 72 hours of life Paul Tait, pharmacist

Respiratory Secretions. Care in the last 72 hours of life Paul Tait, pharmacist Respiratory Secretions Care in the last 72 hours of life Paul Tait, pharmacist 50% Why? Inability to swallow & clear secretions Ineffective cough Reduced consciousness Pooling of secretions in the throat

More information

Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC)

Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC) Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC) May 2018 THE WATERLOO WELLINGTON SYMPTOM MANAGEMENT GUIDELINE FOR THE END OF

More information

Regional Renal Training

Regional Renal Training Regional Renal Training Palliative and End of Life Care Dr Clare Kendall North Bristol NHS Trust Advanced Kidney Disease Dialysis/Transplant Conservative Management Deteriorating despite dialysis/failing

More information

Symptom Control in the Community Setting. Dr Andrew Tysoe-Calnon

Symptom Control in the Community Setting. Dr Andrew Tysoe-Calnon Symptom Control in the Community Setting Dr Andrew Tysoe-Calnon Lead Consultant t Common symptoms Pain Agitation Shortness of breath Nausea and vomiting Intestinal obstruction Confusion Pain Occurs in

More information

Course Handouts & Post Test

Course Handouts & Post Test End Stage Liver Disease (ESLD) End Stage Renal Disease (ESRD) Disease Trajectory and Hospice Eligibility Terri Maxwell PhD, APRN VP, Strategic Initiatives Weatherbee Resources Inc. & Hospice Education

More information

What s New 2003? What new treatments? What have you discontinued? More information please!

What s New 2003? What new treatments? What have you discontinued? More information please! What s New 2003? What new treatments? What have you discontinued? More information please! 1 What s New 2003? Submissions = 137 UK = 52 (38%) Doctors = 60% Nurses = 25% Pharmacists = 15% 2 What s New?

More information

Training in palliative and end-of-life care: Guidance for trainees (and their trainers) in non-palliative medicine training posts

Training in palliative and end-of-life care: Guidance for trainees (and their trainers) in non-palliative medicine training posts Training in palliative and end-of-life care: Guidance for trainees (and their trainers) in non-palliative medicine training posts August 204 Produced by Dr Fiona Hicks onsultant in Palliative Medicine

More information

Specialist Palliative Care Referral for Patients

Specialist Palliative Care Referral for Patients Specialist Palliative Care Referral for Patients This guideline covers referrals for patients with progressive terminal illness, whether due to cancer or other disease. For many patients in the late stages

More information

Palliative care in long-term conditions Scottish Palliative Care Pharmacists Association

Palliative care in long-term conditions Scottish Palliative Care Pharmacists Association Palliative care in long-term conditions 2011 2012 Scottish Palliative Care Pharmacists Association Aims & Objectives To explore symptoms, general management principles and appropriate palliative treatment

More information

Palliative services getting involved: When is the right time? What are the barriers?

Palliative services getting involved: When is the right time? What are the barriers? Palliative services getting involved: When is the right time? What are the barriers? Learning from the NHS report Getting it Right: Improving End of Life Care for liver Disease (2013) Lynda Greenslade

More information

The Continuum of Care for Advanced Liver Disease: Partnering with the Liver Specialist. K V Speeg, MD, PhD UT Health San Antonio

The Continuum of Care for Advanced Liver Disease: Partnering with the Liver Specialist. K V Speeg, MD, PhD UT Health San Antonio The Continuum of Care for Advanced Liver Disease: Partnering with the Liver Specialist K V Speeg, MD, PhD UT Health San Antonio Objectives Review staging of liver disease Review consequences of end-stage

More information

Health Learning Partnership End of Life Care 29 th June 2016

Health Learning Partnership End of Life Care 29 th June 2016 Health Learning Partnership End of Life Care 29 th June 2016 Beth Wright Consultant in Palliative Medicine Case 1 Malignant bowel obstruction Sarah is a 43 year old woman colon cancer, diagnosed in 2014.

More information

Access to Palliative Care Drugs and Advice through Lothian Primary Care NHS Trust Community Pharmacy Palliative Care Network

Access to Palliative Care Drugs and Advice through Lothian Primary Care NHS Trust Community Pharmacy Palliative Care Network Access to Palliative Care Drugs and Advice through Lothian Primary Care NHS Trust Community Pharmacy Palliative Care Network Information for GPs, community pharmacists and district nurses First issued

More information

Policy/Standard Operating Procedure/ Clinical Guideline. ELHT/CP22 Version 5.1. ELHT/CP22 Version 4.1

Policy/Standard Operating Procedure/ Clinical Guideline. ELHT/CP22 Version 5.1. ELHT/CP22 Version 4.1 TRUST WIDE/DIVISIONAL DOCUMENT Delete as appropriate Policy/Standard Operating Procedure/ Clinical Guideline DOCUMENT TITLE: Policy and Procedure for the T34 Ambulatory Syringe Pump in adults (Palliative

More information

Care of dying adults in the last days of life. Improving care at the very end of life.

Care of dying adults in the last days of life. Improving care at the very end of life. Care of dying adults in the last days of life Improving care at the very end of life. Foreword We will all experience death, whether it is our own or that of a loved one. The bereaved person s perception

More information

PRIMARY CARE PALLIATIVE CARE FORMULARY

PRIMARY CARE PALLIATIVE CARE FORMULARY PRIMARY CARE PALLIATIVE CARE FORMULARY This formulary has been developed between West Essex CCG and the palliative care team at St Clare Hospice. The aim of the formulary is to ensure that medicines use

More information

Renal Care and Liver Disease: Disease Trajectory and Hospice Eligibility

Renal Care and Liver Disease: Disease Trajectory and Hospice Eligibility Renal Care and Liver Disease: Disease Trajectory and Hospice Eligibility Terri L. Maxwell PhD, APRN VP, Strategic Initiatives Weatherbee Resources/HEN Course Materials & Disclosure Course materials including

More information

Using Evidence Based Medicine to Ethically Provide End of Life Symptom Control

Using Evidence Based Medicine to Ethically Provide End of Life Symptom Control Using Evidence Based Medicine to Ethically Provide End of Life Symptom Control Erin Zimny, MD Emergency Medicine Hospice and Palliative Medicine Henry Ford Hospital Disclosures I do NOT have any financial

More information

Clatterbridge Centre for Oncology

Clatterbridge Centre for Oncology Clatterbridge Centre for Oncology CONTENTS 1. Why and when to use a syringe driver 2. Siting the syringe driver 3. Mixing and measuring 4. Setting up the syringe driver 5. Drug information 6. Common problems

More information

What else is new (other symptoms) DR ANDREW DAVIES

What else is new (other symptoms) DR ANDREW DAVIES What else is new (other symptoms) DR ANDREW DAVIES Outline Nausea & vomiting Petroleum jelly (and oxygen) Nausea & vomiting MASCC / ESMO recommendations MASCC / ESMO recommendations General: The anti-emetic

More information

The John Walls Renal Unit Leicester General Hospital University Hospitals of Leicester

The John Walls Renal Unit Leicester General Hospital University Hospitals of Leicester The John Walls Renal Unit Leicester General Hospital University Hospitals of Leicester Supportive Care for Renal Patients Author: Renal and Palliative Care Written May 2010; updated May 2012 and Dec 2012

More information

MND Just in Case kit Information for GPs

MND Just in Case kit Information for GPs MND Just in Case kit Information for GPs What is the MND Just in Case kit? 2 Motor neurone disease (MND) is a progressive and terminal disease that results in degeneration of the motor neurones in the

More information

Criteria and Guidance for Referral to Specialist Palliative Care Services

Criteria and Guidance for Referral to Specialist Palliative Care Services Criteria and Guidance for Referral to Specialist Palliative Care Services March 2014 Introduction This guidance is for health professionals caring for patients who may need referral to specialist palliative

More information

Attach patient label here. Physician Orders ADULT: Palliative Care Plan

Attach patient label here. Physician Orders ADULT: Palliative Care Plan Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase T;N, Phase: Palliative Care Phase, When to Initiate: Palliative Care Phase Admission/Transfer/Discharge Patient Status Initial

More information

CARE OF THE DYING PATIENT WITH ESKD ELIZABETH JOSLAND - RSC CNC

CARE OF THE DYING PATIENT WITH ESKD ELIZABETH JOSLAND - RSC CNC CARE OF THE DYING PATIENT WITH ESKD ELIZABETH JOSLAND - RSC CNC OBJECTIVES UNDERSTANDING OF: POTENTIAL COMPLEXITIES OF ESKD PATIENTS IMPORTANCE OF COMMUNICATION CONSIDERATIONS AT END-OF-LIFE END-OF-LIFE

More information

Palliative Patient in Emergency Department

Palliative Patient in Emergency Department Palliative Patient in Emergency Department Dr Thiru Thirukkumaran Palliative Care Services NW THO Northwest Regional Hospital, Burnie Northwest Tasmania Outline the Session Introduction What is palliative

More information

Q&A: Opioid Prescribing for Chronic Non-Malignant Pain

Q&A: Opioid Prescribing for Chronic Non-Malignant Pain NHS Hastings and Rother Clinical Commissioning Group Chair Dr David Warden Chief Officer Amanda Philpott NHS Eastbourne, Hailsham and Seaford Clinical Commissioning Group Chair Dr Martin Writer Chief Officer

More information

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS The benefits of prefilled syringes for palliative care from the hospital pharmacy service In

More information

Overview of Essentials of Pain Management. Updated 11/2016

Overview of Essentials of Pain Management. Updated 11/2016 0 Overview of Essentials of Pain Management Updated 11/2016 1 Overview of Essentials of Pain Management 1. Assess pain intensity on a 0 10 scale in which 0 = no pain at all and 10 = the worst pain imaginable.

More information

If dialysis is not started, established renal failure will eventually lead to death although the time scale is variable from weeks to months.

If dialysis is not started, established renal failure will eventually lead to death although the time scale is variable from weeks to months. Supportive care for adult renal patients with Established Renal Failure : information for GPs and District Nurses RRCV CMG Nephrology Service 1. Introduction 1.1 Supportive care for renal patients Part

More information

Causes of Liver Disease in US

Causes of Liver Disease in US Learning Objectives Updates in Outpatient Cirrhosis Management Jennifer Guy, MD MAS Director, Liver Cancer Program California Pacific Medical Center guyj@sutterhealth.org Review cirrhosis epidemiology,

More information

Supportive and Palliative care for patients with Pancreatic Cancer. Dr Holly Taylor September 2018

Supportive and Palliative care for patients with Pancreatic Cancer. Dr Holly Taylor September 2018 Supportive and Palliative care for patients with Pancreatic Cancer Dr Holly Taylor September 2018 Aims of this session To discuss the principles of supportive and palliative care Identification of patients

More information

Managing Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital.

Managing Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital. Managing Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital. Things to consider: 1. Very common symptoms. 2. Can occur in any

More information

JOURNAL PRESENTATION. Dr Tina Fan Tseung Kwan O Hospital 17 th Jan 2013

JOURNAL PRESENTATION. Dr Tina Fan Tseung Kwan O Hospital 17 th Jan 2013 JOURNAL PRESENTATION Dr Tina Fan Tseung Kwan O Hospital 17 th Jan 2013 THE COMBINATION OF OCTREOTIDE AND MIDODRINE IS NOT SUPERIOR TO ALBUMIN IN PREVENTING RECURRENCE OF ASCITES AFTER LARGE-VOLUME PARACENTESIS

More information

Palliative Care. Anticipatory Prescribing Guidelines & June Gippsland Region Palliative Care Consortium Clinical Practice Group

Palliative Care. Anticipatory Prescribing Guidelines & June Gippsland Region Palliative Care Consortium Clinical Practice Group Palliative Care Anticipatory Prescribing Guidelines June 2016 Gippsland Region Palliative Care Consortium Clinical Practice Group Policy No. Title Keywords Ratified GRPCC-CPG008_1.1_2016 Anticipatory Prescribing

More information

Cancer associated thrombosis palliative care and the end of life. Tracy Anderson May 2017

Cancer associated thrombosis palliative care and the end of life. Tracy Anderson May 2017 Cancer associated thrombosis palliative care and the end of life Tracy Anderson May 2017 Treatment at the end of life Can be challenging to know what treatments are appropriate Benefit vs burden Patients

More information

Lothian Palliative Care Guidelines POCKET EDITION 2004

Lothian Palliative Care Guidelines POCKET EDITION 2004 Lothian Palliative Care Guidelines POCKET EDITION 2004 These guidelines have been developed by a multidisciplinary group of specialist and non-specialist health professionals from hospital, community and

More information

Partnering for Change in Palliative Care in Ontario; Update from the Clinical Advisory Council of the Ontario Palliative Care Network

Partnering for Change in Palliative Care in Ontario; Update from the Clinical Advisory Council of the Ontario Palliative Care Network Partnering for Change in Palliative Care in Ontario; Update from the Clinical Advisory Council of the Ontario Palliative Care Network Ms. Melody Boyd Dr. Ahmed Jakda Ms. Tara Walton Annual Conference April

More information

Managing dying with chronic heart failure

Managing dying with chronic heart failure Heart failure Managing dying with chronic heart failure Chronic heart failure (CHF) is predominantly a pathology of old age affecting 5% of those over 75 years of age. It is more common than cancer and

More information

A Brief Guide to Symptom Management and End of Life Care for Children During Pandemic Influenza

A Brief Guide to Symptom Management and End of Life Care for Children During Pandemic Influenza A Brief Guide to Symptom Management and End of Life Care for Children During Pandemic Influenza Background This guidance is intended ONLY for use in situations where health services are overwhelmed and

More information